L'Oreal USA: Drug Recall
Recall #D-0419-2025 · 03/05/2025
Class II: Risk
Recall Details
- Recall Number
- D-0419-2025
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- L'Oreal USA
- Status
- Ongoing
- Date Initiated
- 03/05/2025
- Location
- Clark, NJ, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
Reason for Recall
cGMP Deviations: The recall was initiated due to detected trace levels of benzene in a specific lot of this product lot (MYX46W), however out of an abundance of caution, the firm voluntarily recalled all La Roche-Posay Effaclar Duo Dual Action Acne Treatment lots.
Product Description
La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl Peroxide Acne Medication, a) UPC 3606000508804, 20 mL (0.7 fl. oz.) Tube per Carton, b) 883140500759, 40 mL (1.35 fl. oz.) Tube per Carton, La Roche-Posay LLC, 10 Hudson Yards, New York, NY 10001, La Roche-Posay, France.
Distribution Pattern
Nationwide in the USA
Other Recalls by L'Oreal USA
- Class II: Risk 03/05/2025
- Class II: Risk 03/05/2025
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.